Tolmachov Oleg, Palaszewski Iwona, Bigger Brian, Coutelle Charles
Division of Biomedical Sciences, Faculty of Natural Sciences, Imperial College London, London SW7 2AZ, UK.
BMC Biotechnol. 2006 Mar 10;6:17. doi: 10.1186/1472-6750-6-17.
Minicircle DNA is the non-replicating product of intramolecular site-specific recombination within a bacterial minicircle producer plasmid. Minicircle DNA can be engineered to contain predominantly human sequences which have a low content of CpG dinucleotides and thus reduced immunotoxicity for humans, whilst the immunogenic bacterial origin and antibiotic resistance marker gene sequences are entirely removed by site-specific recombination. This property makes minicircle DNA an excellent vector for non-viral gene therapy. Large-scale production of minicircle DNA requires a bacterial strain expressing tightly controlled site-specific recombinase, such as Cre recombinase. As recombinant plasmids tend to be more stable in RecA-deficient strains, we aimed to construct a recA- bacterial strain for generation of minicircle vector DNA with less chance of unwanted deletions.
We describe here the construction of the RecA-deficient minicircle DNA producer Escherichia coli HB101Cre with a chromosomally located Cre recombinase gene under the tight control of the araC regulon. The Cre gene expression cassette was inserted into the chromosomal lacZ gene by creating transient homologous recombination proficiency in the recA- strain HB101 using plasmid-born recET genes and homology-mediated chromosomal "pop-in, pop-out" of the plasmid pBAD75Cre containing the Cre gene and a temperature sensitive replication origin. Favourably for the Cre gene placement, at the "pop-out" step, the observed frequency of RecET-led recombination between the proximal regions of homology was 10 times higher than between the distal regions. Using the minicircle producing plasmid pFIXluc containing mutant loxP66 and loxP71 sites, we isolated pure minicircle DNA from the obtained recA- producer strain HB101Cre. The minicircle DNA preparation consisted of monomeric and, unexpectedly, also multimeric minicircle DNA forms, all containing the hybrid loxP66/71 site 5'-TACCGTTCGT ATAATGTATG CTATACGAAC GGTA-3', which was previously shown to be an inefficient partner in Cre-mediated recombination.
Using transient RecET-driven recombination we inserted a single copy of the araC controlled Cre gene into the lacZ gene on the chromosome of E. coli recA- strain HB101. The resultant recA- minicircle DNA producer strain HB101Cre was used to obtain pure minicircle DNA, consisting of monomeric and multimeric minicircle forms. The obtained recA- minicircle DNA producer strain is expected to decrease the risk of undesired deletions within minicircle producer plasmids and, therefore, to improve production of the therapeutic minicircle vectors.
微型环状DNA是细菌微型环状DNA生产质粒分子内位点特异性重组的非复制性产物。微型环状DNA可设计为主要包含人类序列,这些序列的CpG二核苷酸含量低,因此对人类的免疫毒性降低,同时免疫原性细菌来源和抗生素抗性标记基因序列通过位点特异性重组被完全去除。这一特性使微型环状DNA成为非病毒基因治疗的理想载体。大规模生产微型环状DNA需要一种表达严格调控的位点特异性重组酶(如Cre重组酶)的细菌菌株。由于重组质粒在RecA缺陷型菌株中往往更稳定,我们旨在构建一种recA-细菌菌株,以降低产生的微型环状载体DNA发生意外缺失的可能性。
我们在此描述了RecA缺陷型微型环状DNA生产大肠杆菌HB101Cre的构建,其染色体上的Cre重组酶基因受araC调控子的严格控制。通过使用携带recET基因的质粒在recA-菌株HB101中产生瞬时同源重组能力,并通过同源介导的染色体“插入、弹出”含有Cre基因和温度敏感复制起点的质粒pBAD75Cre,将Cre基因表达盒插入染色体lacZ基因。有利于Cre基因定位的是,在“弹出”步骤中,观察到的同源近端区域之间RecET介导的重组频率比远端区域之间高10倍。使用含有突变型loxP66和loxP71位点的微型环状生产质粒pFIXluc,我们从获得的recA-生产菌株HB101Cre中分离出了纯微型环状DNA。微型环状DNA制剂由单体形式以及意外出现的多聚体形式的微型环状DNA组成,所有这些都含有杂交loxP66/71位点5'-TACCGTTCGT ATAATGTATG CTATACGAAC GGTA-3',该位点先前已被证明是Cre介导的重组中的低效配对物。
利用瞬时RecET驱动的重组,我们将单个拷贝的araC控制的Cre基因插入到大肠杆菌recA-菌株HB101染色体上的lacZ基因中。所得的recA-微型环状DNA生产菌株HB101Cre用于获得由单体和多聚体微型环状形式组成的纯微型环状DNA。预期获得的recA-微型环状DNA生产菌株将降低微型环状生产质粒内意外缺失的风险,从而提高治疗性微型环状载体的产量。